Benzinga | Jan 13, 2021 07:31AM EST

Mizuho Downgrades National Health Investors to Underperform, Announces $55 Price Target

Mizuho analyst Omotayo Okusanya downgrades National Health Investors (NYSE:NHI) from Neutral to Underperform and announces $55 price target.